The overall risk of myopericarditis following COVID-19 vaccination is very low, affecting 18 people per million vaccine doses. A new study published in The Lancet Respiratory Medicine, confirms that this risk is comparable ...
Apr 11, 2022
0
1
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy is not associated with adverse pregnancy outcomes, according to a study published online March 24 in the Journal of the American ...
Mar 29, 2022
0
28
U.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given to tens of millions of Americans since its emergency authorization over a year ago.
Jan 31, 2022
0
7
New research published in Nature Medicine reveals willingness to get a COVID-19 vaccine was considerably higher in developing countries (80% of respondents) than in the United States (65%) and Russia (30%).
Jul 16, 2021
0
9
Misleading claims about COVID-19 vaccines can negatively impact public confidence in immunisation uptake, a new UNSW Sydney study reveals.
May 12, 2021
0
3
The public's preference for the AstraZeneca COVID vaccine has declined since last month, and belief that it causes blood clots has increased—but despite this, vaccine confidence is higher than it was towards the end of ...
Apr 28, 2021
0
7
At the start of the year, one of the main causes of the EU's slow rollout of COVID-19 vaccines was lower than expected supplies from AstraZeneca. Fast forward a few weeks and the EU's vaccination program still trails far ...
Mar 10, 2021
0
0
Mark Aulisio, the Susan E. Watson Professor and chair of the Department of Bioethics at Case Western Reserve University School of Medicine, weighed in on bioethical issues that have arisen as a result of the COVID-19 pandemic ...
Feb 3, 2021
0
2
Government leaders should not be allowed to move to the front of the line for COVID-19 vaccinations unless the criteria for such prioritization is well reasoned, clearly articulated in advance, and transparently applied, ...
Jan 26, 2021
0
18
The co-founder of BioNTech said Tuesday it was "highly likely" that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it could also adapt the vaccine if necessary in six weeks.
Dec 22, 2020
0
69
